The optimal therapy strategy for epidermal growth factor receptor-mutated non-small cell lung cancer patients with brain metastasis: A real-world study from Taiwan.
Wen-Chien ChengYi-Cheng ShenChun-Ru ChienWei-Chih LiaoChia-Hung ChenTe-Chun HsiaChih-Yeh TuHung-Jen ChenPublished in: Thoracic cancer (2022)
The study demonstrated that EGFR-mutant NSCLC patients with BMs could be precisely treated with SRS according to Lung-mol GPA ≥3. Sequential osimertinib was associated with prolonged survival, regardless of T790M status.